News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
FDA
Bayer Corporation Gets Japan Approval for Kidney Cancer Drug
January 28, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
TOKYO, Jan 28 (Reuters) - German drug maker Bayer AG said on Monday its drug Nexavar had been approved in Japan for the treatment of advanced kidney cancer, beating rival makers of similar therapies to the market here.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
Asia
Bayer
MORE ON THIS TOPIC
FDA
BIO CEO Crowley, DOD doctor Overton are top candidates for FDA commissioner: RBC
June 24, 2026
·
3 min read
·
Heather McKenzie
Deals
Lilly deepens relationship with China’s Abbisko for $1.9B biobucks
June 24, 2026
·
2 min read
·
Tristan Manalac
Podcast
AbbVie keeps M&A rolling, FDA’s reversal train chugs along, BIO 2026 dispatch, more
June 24, 2026
·
1 min read
·
Jef Akst
Bankruptcy
Lilly, Astellas circle Sangamo assets as biotech files for bankruptcy
June 23, 2026
·
3 min read
·
Gabrielle Masson
